Avastin Effective At Delaying Brain Tumor Progression In Recurrent Disease

The use of Avastin alone to treat a subgroup of recurrent Grade 3 brain tumors showed it was safe and effective at delaying tumor progression, according to a retrospective study of 22 patients conducted by a researcher at the Seattle Cancer Care Alliance. The patients all had a recurrent malignant glioma known as alkylator-refractory anaplastic oligodendroglioma (AO), for which there is no existing standard therapy.

More: continued here

Filed under: Neurology / Neuroscience on April 10th, 2009